Fund shareholders of Iovance Biotherapeutics Inc
ISIN US4622601007 · United States · LEI 2549002L8WT2ACU5Q878
- Fund shareholders
- 171
- Of which ETFs
- 43 128 other funds
- Value held
- 305.3M $
- Share of capital
- 19.2 % of 453M shares on Jul 29, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| SA Small Cap Index Portfolio SUNAMERICA SERIES TRUST | 34,723 | 116.7K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares U.S. Tech Breakthrough Multisector ETF iShares Trust | 32,729 | 110K $ | 0.02 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 32,662 | 126.1K $ | 0.10 % | 0.01 % | as of Feb 28, 2026 ↗ |
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 28,253 | 99.2K $ | 0.08 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 27,891 | 107.7K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| CVT Russell 2000 Small Cap Index Portfolio Calvert Variable Trust, Inc. | 27,607 | 96.9K $ | 0.04 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VY(R) JPMORGAN SMALL CAP CORE EQUITY PORTFOLIO Voya Investors Trust | 27,158 | 95.3K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 26,738 | 103.2K $ | 0.73 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Nationwide Small Cap Index Fund Nationwide Mutual Funds | 26,615 | 89.4K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Small Cap Equity Insights Fund Goldman Sachs Trust | 25,545 | 85.8K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 24,950 | 87.6K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 24,921 | 96.2K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| SIMT Small Cap Fund SEI INSTITUTIONAL MANAGED TRUST | 24,190 | 84.9K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Venerable Small Cap Index Fund Venerable Variable Insurance Trust | 23,494 | 82.5K $ | 0.04 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 23,467 | 82.4K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 22,424 | 78.7K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 22,091 | 85.3K $ | 0.11 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Nuveen Life Small Cap Equity Fund TIAA-CREF Life Funds | 21,340 | 74.9K $ | 0.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 20,932 | 73.5K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 19,250 | 74.3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 19,037 | 73.5K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 18,972 | 73.2K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 18,330 | 70.8K $ | 0.08 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 18,065 | 60.7K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 18,001 | 60.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 17,412 | 61.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Sustainability Core 1 ETF Dimensional ETF Trust | 16,834 | 56.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 15,226 | 53.4K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 14,850 | 49.9K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 14,240 | 47.8K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 13,326 | 51.4K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 12,703 | 49K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Federated Hermes Global Allocation Fund Federated Hermes Global Allocation Fund | 12,219 | 47.2K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 11,912 | 41.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 11,305 | 39.7K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 10,926 | 36.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 10,843 | 38.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Core Equity Fund JNL Series Trust | 9,797 | 34.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 9,386 | 31.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 9,107 | 32K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 7,965 | 28K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 7,900 | 27.7K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 7,637 | 29.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 7,247 | 25.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 7,077 | 24.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 6,345 | 22.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Motley Fool Next Index ETF RBB Fund, Inc. | 5,899 | 22.8K $ | 0.07 % | 0.00 % | as of Feb 28, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 5,273 | 18.5K $ | 0.82 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage SMID Cap V.I. Fund BlackRock Variable Series Funds, Inc. | 4,146 | 14.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Motley Fool Capital Efficiency 100 Index ETF RBB Fund, Inc. | 4,009 | 15.5K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 3,807 | 12.8K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 3,405 | 12K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Small Company Value Portfolio Wilshire Mutual Funds Inc | 2,740 | 9.6K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 1,985 | 6.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 1,653 | 5.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| New Covenant Growth Fund NEW COVENANT FUNDS | 1,433 | 5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 1,355 | 4.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 1,348 | 5.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Small Company Growth Portfolio Wilshire Mutual Funds Inc | 1,176 | 4.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 1,141 | 3.8K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 1,128 | 4K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 852 | 3K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Motley Fool Innovative Growth Factor ETF RBB Fund, Inc. | 770 | 3K $ | 0.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 702 | 2.5K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 615 | 2.1K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 455 | 1.6K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 334 | 1.2K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 315 | 1.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 112 | 376.3 $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 95 | 366.7 $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 87 | 305.4 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Virtus Biotech Etf ETFis Series Trust I | 2.44 % | as of Apr 30, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 1.24 % | as of Apr 30, 2026 ↗ |
| Invenomic Fund NORTHERN LIGHTS FUND TRUST II | 1.17 % | as of Apr 30, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 0.82 % | as of Mar 31, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.73 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.38 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.37 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 0.30 % | as of Apr 30, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 0.27 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF SPDR SERIES TRUST | 0.20 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 171 | +24 | 86,805,315 | +15.6 % |
| 2026Q1 | 147 | -13 | 75,094,580 | +15.5 % |
| 2025Q4 | 160 | -1 | 65,030,130 | +3.7 % |
| 2025Q3 | 161 | -25 | 62,738,267 | -22.6 % |
| 2025Q2 | 186 | -10 | 81,106,808 | +1.1 % |
| 2025Q1 | 196 | -5 | 80,216,093 | +2.9 % |
| 2024Q4 | 201 | +6 | 77,972,027 | +14.5 % |
| 2024Q3 | 195 | -16 | 68,099,020 | -0.0 % |
| 2024Q2 | 211 | +36 | 68,120,597 | +1.0 % |
| 2024Q1 | 175 | -1 | 67,461,951 | -0.9 % |
| 2023Q4 | 176 | 68,075,872 |
Institutional managers
274 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 31,080,505 | 109.1M $ | as of Mar 31, 2026 |
| MHR FUND MANAGEMENT LLC | 28,967,103 | 101.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 17,448,108 | 61.2M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 13,687,433 | 48M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 9,414,292 | 33M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 8,760,060 | 30.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 8,572,598 | 30.1M $ | as of Mar 31, 2026 |
| Invenomic Capital Management LP | 8,495,551 | 29.8M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 8,490,119 | 29.8M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 8,016,353 | 28.1M $ | as of Mar 31, 2026 |
| Palo Alto Investors LP | 6,349,563 | 22.3M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 6,201,282 | 21.8M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 4,173,886 | 14.7M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 3,664,278 | 12.9M $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 3,486,299 | 12.2K $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,166,861 | 11.1K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,996,743 | 10.5M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 2,875,526 | 10.1M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,783,730 | 9.8M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 2,645,702 | 9.3M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 2,611,345 | 9.2M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 2,500,624 | 8.3M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 2,355,612 | 8.3M $ | as of Mar 31, 2026 |
| Long Focus Capital Management, LLC | 2,100,000 | 7.4M $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 2,071,524 | 7.3M $ | as of Mar 31, 2026 |
Declared shareholders of Iovance Biotherapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| STATE STREET CORPORATION | 4.20 % | 17,448,108 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Iovance Biotherapeutics Inc". https://titelia.com/en/stocks/iovance-biotherapeutics-inc-US4622601007